|
|
|
40
|
A6911
|
TRILEPTAL 300MG TAB (NVS/COL) OXCARBAZEPINE
|
OXCARBAZEPINE
|
TRILEPTAL
|
20'S
|
C
|
27.18
|
1.36
|
TABLET
|
0
|
TAB
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A6911
|
TRILEPTAL 300MG TAB (NVS) OXCARBAZEPINE (C)
|
OXCARBAZEPINE
|
TRILEPTAL
|
20'S
|
C
|
27.18
|
1.3592
|
TAB
|
120
|
BOX
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
A6911
|
TRILEPTAL 300MG TAB (NVS) OXCARBAZEPINE
|
OXCARBAZEPINE
|
TRILEPTAL
|
20'S
|
C
|
20.39
|
1.02
|
TAB
|
120
|
BLIS
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
A691J
|
APO-OXCARBAZEPINE 300MG TAB (APO/COL)
|
OXCARBAZEPINE
|
APO-OXCARBAZEPINE
|
100'S
|
A
|
59.42
|
0.59
|
TABLET
|
120
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
A691J
|
APO-OXCARBAZEPINE 300MG TAB (APO) O
|
OXCARBAZEPINE
|
APO-OXCARBAZEPINE
|
100'S
|
A
|
60.62
|
0.61
|
TAB
|
120
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
41
|
A691L
|
OXCARBAZEPINE 300MG TAB (CAM)
|
OXCARBAZEPINE
|
OXCARBAZEPINE
|
50'S
|
A
|
23.46
|
0.4692
|
TAB
|
120
|
BOTT
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
41
|
A691N
|
APO-OXCARBAZEPINE 300MG TAB (APO) O
|
OXCARBAZEPINE
|
APO-OXCARBAZEPINE
|
100'S
|
A
|
60.62
|
0.6062
|
TAB
|
120
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
A692E
|
APO-OXCARBAZEPINE 600MG TAB (APO/COL)
|
OXCARBAZEPINE
|
APO-OXCARBAZEPINE
|
100'S
|
A
|
78.83
|
0.79
|
TABLET
|
120
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
A692E
|
APO-OXCARBAZEPINE 600MG TAB (APO) O
|
OXCARBAZEPINE
|
APO-OXCARBAZEPINE
|
100'S
|
A
|
80.41
|
0.80
|
TAB
|
120
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
41
|
A692F
|
OXCARBAZEPINE 600MG TAB (CAM)
|
OXCARBAZEPINE
|
OXCARBAZEPINE
|
50'S
|
A
|
37.68
|
0.7535
|
TAB
|
120
|
BOTT
|
CAM
|
MORNINGSIDE PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
41
|
A692H
|
APO-OXCARBAZEPINE 600MG TAB (APO) O
|
OXCARBAZEPINE
|
APO-OXCARBAZEPINE
|
100'S
|
A
|
80.41
|
0.8041
|
TAB
|
120
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
A6931
|
TRILEPTAL 60MG/ML SUSP (NVS/COL) OXCARBAZEPIN
|
OXCARBAZEPINE
|
TRILEPTAL
|
100ML
|
A
|
27.35
|
0.27
|
SUSPENSION
|
600
|
ML
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
A6931
|
TRILEPTAL 60MG/ML SUSP (NVS) OXCARBAZEPI
|
OXCARBAZEPINE
|
TRILEPTAL
|
100ML
|
A
|
27.35
|
0.2735
|
ML
|
600
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
42
|
A6931
|
TRILEPTAL 60MG/ML SUSP (NVS) OXCARBAZEPI
|
OXCARBAZEPINE
|
TRILEPTAL
|
100ML
|
A
|
27.35
|
0.27
|
ML
|
600
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
B
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTICONVULSANTS MISCELLANEOUS
|
|